CONTENTS Chapter 1 INTRODUCTION TO SUBSTANCE ABUSE COUNSELING 1 The History of Substance: No Wonder We Use 4 Alcohol 4 Cocaine 6 Heroin 7 Marijuana 7 Opioids 8 Amphetamines 10 Hallucinogens 10 Tobacco 11 Caffeine 12 Societal Costs of ATOD Use, Abuse, and Dependency 13 Substance-Related Diseases 14 Hepatitis 14 HIV/AIDS 16 The Importance of Terminology in Substance Abuse Counseling 17 The Profession in the 21st Century 19 An Overview of this Book 20 Conclusion 20 Chapter 2 ETHICAL AND LEGAL ISSUES IN SUBSTANCE ABUSE COUNSELING 27 Education and Training of Substance Abuse Counselors 28 Ethics 30 Confidentiality 32 Code of Federal Regulations 42, Part 2 34 Health Insurance Portability and Accountability Act of 1996 (HIPAA) 35 Confidentiality in Group Counseling or 12-Step Groups 36 Confidentiality of Minors 37 Multiculturalism, Diversity, and Ethics 41 Ethical Conflicts Specific to Substance Abuse Counselors 42 Dual Relationships 42 Clients and Criminal Activity 43 Conflicting Laws 44 Ethical Code Conflicts 44 Contents xiii Ethical Decision Making 44 Conclusion 50 Chapter 3 THE MAJOR SUBSTANCES OF ABUSE AND THE BODY 51 The Brain 52 Neuroscience Research 52 The Structure of the Brain 53 Psychoactive Substances and the Brain 58 Controlled Substances Schedules 59 Depressants 59 Alcohol 60 Benzodiazepines: Prescription and Over-the-Counter Medications 64 Barbiturates 66 GHB (Identified as a Club Drug) 67 Opiates (Prescription Drugs Often Abused) 69 Stimulants 71 Cocaine 71 Amphetamines 74 Minor Stimulant: Nicotine 76 Minor Stimulant: Caffeine 78 Cannabis 79 Hallucinogens 82 Lysergic Acid Diethylamide (LSD) 83 Phencyclidine (PCP) 84 Ketamine (Targeted as a Club Drug) 85 A Further Look at Club Drugs 86 MDMA (Ecstasy) 86 Volatile Substances or Inhalants 88 Anabolic-Androgenic Steroids 89 Conclusion 92 Chapter 4 ETIOLOGY OF SUBSTANCE ABUSE: WHY PEOPLE USE 98 Understanding Theory 98 Overview of ATOD Theories 99 Moral Theory 99 Aspects of Use Addressed by the Moral Theory 99 Disease Theory 101 Aspects of Use Addressed by the Disease Theory 101 xiv Contents Genetic Theories 105 Aspects of Use Addressed by Genetic Theories 107 Behavioral Theories 110 Aspects of Use Addressed by the Behavioral Theory 111 Sociocultural Theories 114 Aspects of Use Addressed by Sociocultural Theories 115 An Integrated Approach 119 Conclusion 121 Chapter 5 ASSESSMENT AND DIAGNOSIS 122 Issues in Assessment 122 The Diagnostic Interview 124 DSM-IV-TR DIAGNOSIS 126 Criteria for Substance Dependence 126 Criteria for Substance Abuse 127 Behavioral Characteristics 127 Phase 1: The Prodomal Phase 128 Phase 2: The Crucial Phase 130 Phase 3: The Chronic Phase 131 Assessing the Behavioral Symptoms 132 Social Characteristics 132 Family Characteristics 132 Assessing the Social and Family-Related Symptoms 135 Screening and Assessment Instruments 136 The Michigan Alcoholism Screening Test (MAST) 137 The Short Michigan Alcoholism Screening Test (SMAST) 138 The Drug Abuse Screening Test (DAST-20) 138 The CAGE Questionnaire 138 The Substance Abuse Subtle Screening Inventory (SASSI-3 and SASSI-A2) 139 The Alcohol Use Inventory (AUI) 140 The Addiction Severity Index (ASI) 140 The Adolescent Diagnostic Interview (ADI) 141 The Millon Clinical Multiaxial Inventory (MCMI-II) and Minnesota Multiphasic Personality Inventory (MMPI-2) 141 The ASAM Criteria for Patient Placement 142 Diagnosis 143 Differential Diagnosis 143 Dual Diagnosis 144 Contents xv Chapter 6 TREATMENT SETTING AND TREATMENT PLANNING 155 What Is a Treatment Setting? 156 Types of Treatment Settings 157 Medical Detoxification and Stabilization 157 Dual-Diagnosis Hospital Inpatient 158 Free-Standing Rehabilitation and Residential Programs 159 Partial Hospitalization 164 Temporary Recovery or Halfway Homes 164 Intensive Outpatient 164 The Importance of Matching Treatment to Client Needs 167 What Is Treatment Planning? 168 How to Develop a Treatment Plan 170 The Elements of a Severe Substance Use Disorder Treatment Plan 171 Sample Substance Use Treatment Plan: Relationship Factors 171 External Reviewers of Treatment Planning: Health Care Accreditation Organizations and Managed Care 175 Conclusion 178 Treatment of Drug and Alcohol Problems in the Military 185 Chapter 7 INDIVIDUAL TREATMENT 188 Beginning Individual Treatment 189 Intervention 189 Individual Therapy 191 Therapeutic Alliance 191 Direct Effect Strategies 191 Motivational Interviewing 191 Cognitive-Behavioral Therapy 192 Mindfulness Technique 193 Pharmacotherapy 193 Broad Spectrum Strategies 195 Harm Reduction 195 Harm Reduction from the Therapist's Perspective 196 Coping Skills Training/Life Skills Training 197 Vocational Readiness 197 Support Groups 198 Conclusion 201 XVI Contents Chapter 8 GROUP TREATMENT IN THE CONTINUUM OF CARE 203 Evolution of Group Treatment 204 Group Dynamics, Process, and Structure 207 Curative Factors in Group Treatment 207 Group Dynamics 209 Stages of Group Development 212 Structural Considerations 216 Group Treatment in the Continuum of Care 217 Prevention 218 Detoxification and Inpatient Treatment 218 Residential Treatment 219 Partial Hospitalization and Day Treatment 219 Aftercare and Sober Living 220 Outpatient Groups and Community Care 220 Pragmatics of Group Treatment 221 Therapeutic Community 221 Self-Help Groups 222 Psychoeducational Groups 222 Cognitive and Behavioral Interventions 223 Group Psychotherapy 228 Relational Therapy and Family Groups 229 Group Treatment Efficacy 232 Conclusion 238 Chapter 9 FAMILY TREATMENT 240 Defining Family 242 General Systems Concepts 243 Homeostasis 244 Feedback Loops 244 Hierarchy, Roles, Rules, Subsystems, and Boundaries 245 Wholeness 246 Change 247 Values 247 Systems and Addictive Families 247 The Marital Dyad and Substance Abuse 248 The Family and Substance Abuse 250 Children in the Addicted Family 252 Treatment with Addictive Families 253 Contents xvii The Process of Treatment 255 Programs Utilizing Family Therapy 255 How Successful Is Family Therapy? 256 Conclusion 260 Chapter 10 RETAINING SOBRIETY: RELAPSE PREVENTION STRATEGIES 261 Determinants of Relapse 263 Environmental 263 Behavioral 264 Cognitive 265 Affective 265 Interpersonal Determinants 266 Summary 267 Models of Relapse Planning and Management 267 The Disease Model 267 Developmental Models 268 A Cognitive-Behavioral/Social Learning Model 271 Self-Help Recovery Organizations: Adjuncts to Professional Intervention 274 Alcoholics Anonymous Model 275 Spirituality as a Resource 277 AA-Associated 12-Step Programs 278 Moderation Management (MM) 278 Rational Recovery 280 Secular Organizations for Sobriety/Save our Selves (SOS) 281 Women for Sobriety (WFS) 281 Self-Help for Dually Diagnosed Persons 283 A Well-Rounded Life with Joy 283 Conclusion 286 Chapter 11 WORKING WITH SELECTED POPULATIONS: TREATMENT ISSUES AND CHARACTERISTICS 287 Children and Adolescents 287 Risk Factors 290 Prevention and Intervention 291 Women 294 Risk Factors 294 Prevention and Intervention 295 xviii Contents The Gay/Lesbian/Bisexual/Transgender Community 297 Gay/Lesbian/Bisexual/Transgender Identity Development 298 Risk Factors 298 Prevention and Intervention 299 People with Disabilities 300 Risk Factors 301 Prevention and Intervention 302 Older Adults 304 Risk Factors 304 Prevention and Intervention 305 Homelessness 306 Risk Factors 307 Treatment 308 Conclusion 310 Chapter 12 WORKING WITH DIVERSE CULTURES: EXPLORING SOCIOCULTURAL INFLUENCES AND REALITIES IN ATOD TREATMENT AND PREVENTION 311 American Indians and Alaskan Natives 312 Cultural Values 314 Risk Factors 315 Barriers to Treatment 316 Prevention and Intervention 317 Asian Americans 318 Cultural Values 320 Risk Factors 321 Prevention and Intervention 322 African Americans 324 Risk Factors 325 Cultural Values 326 Barriers to Treatment 327 Prevention and Intervention 327 Hispanics 328 Cultural Values 330 Barriers to Treatment 331 Prevention and Intervention 333 Conclusion 334 Contents xix Chapter 13 PREVENTION 336 Types of Prevention 339 Prevention: A Brief History 340 Comprehensive Prevention 343 Community Prevention 344 Risk and Protective Factors 346 Life Skills Training (LST): Effectiveness of a Comprehensive Prevention Approach 349 Steps to an Effective Prevention Program 350 Implications for Counseling 353 Conclusion 356 References 358 Index 392 Introduction to Substance Abuse Counseling Patricia Stevens, Ph.D. MyCounselingLab Visit the MyCounselingLab' site for Substance Abuse Counseling, Fifth Edition to enhance your understanding of chapter concepts. You'll have the opportunity to practice your skills through video- and case-based Assignments and Activities as well as Building Counseling Skills units, and to prepare for your certification exam with Practice for Certification quizzes. Icohol, tobacco, caffeine, prescription drugs, illegal drugs—all are commonplace words today. Alcohol, tobacco, and other drugs (ATOD) are used for celebrations, for mourning, for religious rituals, for pain relief, and recreationally. We read about them in the newspaper daily, we hear about them on the radio and television, and we can find just about anything, from what they are to how to make them, about any substance use and abuse on the Internet. We see children abusing at younger ages and elders abusing. Drugs are misused to forget, to feel better or not feel at all, to be friendly, to disinhibit, and because of peer pressure. Tobacco and alcohol, legal drugs, are used and abused with social sanction and are easily available. If we don't use them, we probably have a user/abuser in the family or a close friend who has abused, or know someone who uses alcohol or other drugs inappropriately. Consequences of use and abuse of legalized substances continue to be minimized in a variety of settings. Until the mid-1990s, the tobacco industry denied addiction while people were dying from lung cancer and others continued to smoke. After multiple suits against the companies, they tried to settle, paying out $10 billion per year in perpetuity and placing in the public domain over 35 million pages of internal documents on the effects of smoking. In 2009, an estimated 69.7 million Americans aged 12 or older were current (past month) users of a tobacco product. This represents 27.7% of the population 1
Description: